Pennsylvania 2025_0 Regular Session Status: In Committee

HB 2747 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

Last action — Referred to JUDICIARY, Aug. 25, 2026

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced August 25, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 18% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 3 sponsors

    1 primary, 2 co-sponsors signed on.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

This bill permanently schedules Nitazene compounds as controlled substances.

The bill amends existing drug laws to permanently categorize Nitazene compounds as controlled substances. This change is intended to regulate their use and distribution more strictly.

Summary

Permanently Scheduling Nitazene Compounds

Bill Text

How this bill changes current law

1 change Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill amends the Controlled Substance, Drug, Device and Cosmetic Act to add specific synthetic benzimidazole-opioids to Schedule I of controlled substances.

  • Section 4(1)

    Any of the following synthetic benzimidazole-opioid (Nitazenes) substances, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers whenever the existence of the isomers, esters, ethers and salts is possible: 1. 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (butonitazene). 2. 2-(2-(4-ethoxybenzyl)-1Hbenzimidazol-1-yl)-N,Ndiethylethan-1-amine (etodesnitazene; etazene). 3. N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (flunitazene). 4. N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (metodesnitazene). 5. N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)ethan-1-amine (metonitazene). 6. 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1Hbenzimidazole (N-pyrrolidino etonitazene; etonitazepyne). 7. N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene). 8. N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (isotonitazene).

    This change adds eight specific synthetic opioids to the list of substances classified as Schedule I, which are considered to have a high potential for abuse and no accepted medical use.

Action History

  1. Referred to JUDICIARY, Aug. 25, 2026

Sponsors

  • HEFFLEY · Primary
  • KUZMA · Cosponsor
  • MOUL · Cosponsor

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 2 co-sponsors · 250 not signed on

Sponsors (1)

  • HEFFLEY

Co-sponsors (2)

  • KUZMA
  • MOUL

Not signed on (250)

250 members have not signed on to this bill.

Show all 250 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 2747 do?
Permanently Scheduling Nitazene Compounds
Who sponsors HB 2747?
HB 2747 is sponsored by HEFFLEY, KUZMA, and MOUL.
What is the current status of HB 2747?
This bill is in committee in the House. Introduced August 25, 2026. It must pass committee before a floor vote.
Where can I track HB 2747?
Track HB 2747 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2747

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 2747

Last checked for changes about 1 month ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →